Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Bullfrog Ai Holdings WT (BFRGW)

Bullfrog Ai Holdings WT (BFRGW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BullFrog AI Publishes Whitepaper on AI in Bioinformatics: Turning Complex Data into Actionable Insights GlobeNewswire - Tue Nov 18, 8:00AM CST

GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc.  (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...

BFRG : 1.1500 (+5.50%)
BFRGW : 0.3791 (+9.47%)
BullFrog AI to Present bfPREP at the AI Drug Discovery & Development Summit 2025 GlobeNewswire - Wed Nov 12, 7:00AM CST

GAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc.  (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...

BFRG : 1.1500 (+5.50%)
BFRGW : 0.3791 (+9.47%)
BullFrog AI Announces Abstract Accepted for Presentation at 2026 ASCO Gastrointestinal Cancers Symposium GlobeNewswire - Tue Nov 4, 7:00AM CST

AI-driven precision-oncology analysis identifies patient subtypes with potential enhanced response to glufosfamide Accepted ASCO abstract, submitted in collaboration with Eleison Pharmaceuticals,...

BFRG : 1.1500 (+5.50%)
BFRGW : 0.3791 (+9.47%)
Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on October 30 GlobeNewswire - Thu Oct 30, 7:00AM CDT

GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...

BFRG : 1.1500 (+5.50%)
BFRGW : 0.3791 (+9.47%)
BullFrog AI Expands Sales and Marketing Team to Accelerate Commercial Adoption of Clinical Trial Optimization Solutions and bfPREP™ Module GlobeNewswire - Tue Sep 30, 7:00AM CDT

GAITHERSBURG, Md., Sept. 30, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc.  (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...

BFRG : 1.1500 (+5.50%)
BFRGW : 0.3791 (+9.47%)
BullFrog AI and Sygnature Discovery Announce Official Sales Launch of BullFrog Data Networks™ to Global Biopharma Clients GlobeNewswire - Thu Sep 25, 7:00AM CDT

GAITHERSBURG, Md., Sept. 25, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc.  (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...

BFRG : 1.1500 (+5.50%)
BFRGW : 0.3791 (+9.47%)
BullFrog AI to Showcase AI-Powered Clinical Data Solutions in Xtalks Webinar GlobeNewswire - Tue Sep 23, 7:00AM CDT

GAITHERSBURG, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc.  (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...

BFRG : 1.1500 (+5.50%)
BFRGW : 0.3791 (+9.47%)
BullFrog AI’s bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration GlobeNewswire - Mon Sep 8, 7:00AM CDT

Joint oncology conference submission planned and follow-on contract discussion underway Validates BullFrog AI’s enterprise-grade platform strategy, combining automation and human-in-the-loop...

BFRG : 1.1500 (+5.50%)
BFRGW : 0.3791 (+9.47%)
BullFrog AI to Present at BTIG Annual Virtual Biotechnology Conference GlobeNewswire - Mon Jul 28, 3:30PM CDT

GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc.  (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial...

BFRG : 1.1500 (+5.50%)
BFRGW : 0.3791 (+9.47%)
Rethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug Development GlobeNewswire - Tue Jul 22, 7:00AM CDT

From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence In a $200B+ market crowded with black-box AI, BullFrog AI’s...

BFRG : 1.1500 (+5.50%)
BFRGW : 0.3791 (+9.47%)

Barchart Exclusives

Is This Dividend Stock a Buy for 2026 After Rising 265% in 2025? Barchart - Thu Dec 4, 6:30PM CST
Anglogold Ashanti shares have soared this year amid a spike in gold prices. While the shares might take a breather for now, it is a buy-on-the-dip candidate for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot